Linked Life Data

17158212

Source:http://linkedlifedata.com/resource/pubmed/id/17158212

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2007-3-26
pubmed:abstractText
Anti-tumour necrosis factor (TNF)-alpha therapies are considered category B drugs for pregnancy. Although sometimes prescribed to women of reproductive age, data in humans are limited with regard to safety for a developing fetus. The objectives of the present article are to report experience of anti-TNF-alpha use in pregnancy, and review the international literature.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1462-0324
pubmed:author
pubmed:issnType
Print
pubmed:volume
46
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
695-8
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:17158212-Antibodies, Monoclonal, pubmed-meshheading:17158212-Antibodies, Monoclonal, Humanized, pubmed-meshheading:17158212-Antirheumatic Agents, pubmed-meshheading:17158212-Arthritis, Juvenile Rheumatoid, pubmed-meshheading:17158212-Arthritis, Psoriatic, pubmed-meshheading:17158212-Arthritis, Rheumatoid, pubmed-meshheading:17158212-Female, pubmed-meshheading:17158212-Humans, pubmed-meshheading:17158212-Immunoglobulin G, pubmed-meshheading:17158212-Maternal-Fetal Exchange, pubmed-meshheading:17158212-Pregnancy, pubmed-meshheading:17158212-Pregnancy Complications, pubmed-meshheading:17158212-Pregnancy Outcome, pubmed-meshheading:17158212-Prospective Studies, pubmed-meshheading:17158212-Receptors, Tumor Necrosis Factor, pubmed-meshheading:17158212-Tumor Necrosis Factor-alpha
pubmed:year
2007
pubmed:articleTitle
Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy.
pubmed:affiliation
Rheumatology Department, University Hospital, Nice, France. roux101fr@yahoo.fr
pubmed:publicationType
Journal Article, Review, Case Reports